The dual role of innate immunity in the antiphospholipid syndrome

Lupus

Volumn 19, Issue 4, 2010, Pages 347-353

  Rauch, J ^a   Dieude M ^a,c   Subang, R ^a   Levine, J S ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

2 glycoprotein I; Antiphospholipid syndrome; Heat shock protein 60; Innate immunity; Lipopolysaccharide; Toll like receptor ligands

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CYTOKINE; HEAT SHOCK PROTEIN 60; LIPOPOLYSACCHARIDE; PHOSPHOLIPID ANTIBODY; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIPHOSPHOLIPID SYNDROME; ARTERY INJURY; CYTOKINE PRODUCTION; DISEASE MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INNATE IMMUNITY; LIGAND BINDING; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; THROMBOSIS; TOLL-LIKE RECEPTORS;

EID: 77951232891     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310361492     Document Type: Review

References (28)

1. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002 ; 346: 752-763. (Pubitemid 34983997)
3. Baker Jr WF, Bick RL The clinical spectrum of antiphospholipid syndrome. Hematol Oncol Clin North Am 2008 ; 22: 33-52.
4. Ziporen L., Shoenfeld Y. Anti-phospholipid syndrome: from patients bedside to experimental animal models and back to the patients bedside. Hematol Cell Ther 1998 ; 40: 175-182. (Pubitemid 28500724)
5. Levine JS, Subang R., Nasr SH, et al. Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus. J Immunol 2006 ; 177: 6504-6516. (Pubitemid 44628870)
6. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003 ; 349: 1526-1533. (Pubitemid 37255038)
7. Raschi E., Testoni C., Bosisio D., et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003 ; 101: 3495-3500. (Pubitemid 36857933)
8. Sorice M., Longo A., Capozzi A., et al. Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor ± and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 2007 ; 56: 2687-2697. (Pubitemid 47237287)
9. Ma K., Simantov R., Zhang J-C., et al. High affinity binding of β2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem 2000 ; 275: 15541-15548. (Pubitemid 30337288)
10. Zhou H., Ling S., Yu Y., et al. Involvement of annexin A2 in anti-β2GPI/β2GPI-induced tissue factor expression on monocytes. Cell Res 2007 ; 17: 737-739. (Pubitemid 47255945)
11. Fischetti F., Durigutto P., Pellis V., et al. Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor. Blood 2005 ; 106: 2340-2346. (Pubitemid 41510805)
12. Pierangeli SS, Barker JH, Stikovac D., et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994 ; 71: 670-674. (Pubitemid 2108697)
13. Kawai T., Akira S. Toll-like receptor and RIG-1-like receptor signaling. Ann NY Acad Sci 2008 ; 1143: 1-20.
14. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007 ; 449: 819-826. (Pubitemid 47598622)
15. Mollen KP, Anand RJ, Tsung A., et al. Emerging paradigm: Toll-like receptor 4 - sentinel for the detection of tissue damage. Shock 2006 ; 26: 430-437. (Pubitemid 44632271)
16. Tsan M-F., Gao B. Endogenous ligands of toll-like receptors. J Leukoc Biol 2004 ; 76: 514-519. (Pubitemid 39129081)
17. Price BE, Rauch J., Shia MA, et al. Antiphospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a β2-glycoprotein I-dependent manner. J Immunol 1996 ; 157: 2201-2208. (Pubitemid 126449701)
18. Casciola-Rosen LA, Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994 ; 179: 1317-1330. (Pubitemid 24091790)
19. Mevorach D., Zhou JL, Song X., Elkon KB Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998 ; 188: 387-392. (Pubitemid 28357766)
20. McAleer JP, Zammit DJ, Lefran§ois L., et al. The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells. J Immunol 2007 ; 179: 6524-6535.
21. Pierangeli SS, Harris EN In vivo models of thrombosis for the antiphospholipid syndrome. Lupus 1996 ; 5: 451-455. (Pubitemid 26354065)
22. Pierangeli SS, Vega-Ostertag ME, Raschi E., et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis 2007 ; 66: 1327-1333. (Pubitemid 47492476)
23. Dieudé M., Gillis M. -A, Théorêt J-F., et al. Autoantibodies to heat shock protein 60 (HSP60) promote thrombus formation in a murine model of arterial thrombosis. J Thromb Haemost 2009 ; 7: 710-719.
24. Dieudé M., Senécal JL, Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum 2004 ; 50: 3221-3231. (Pubitemid 39371999)
25. Habich C., Burkart V. Heat shock protein 60: regulatory role on innate immune cells. Cell Mol Life Sci 2007 ; 64: 742-751. (Pubitemid 46474983)
26. Dieudé M., Correa J., Neville C., et al. Autoantibodies to heat shock protein 60 are associated with arterial vascular events in patients with anti-phospholipid antibodies. Arthritis Rheum 2009 ; 60: S766 (abstract).
27. Bucciarelli S., Espinosa G., Cervera R., et al. Mortality in catastrophic antiphospholipid syndrome. Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006 ; 54: 2568-2576. (Pubitemid 44205018)
28. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008 ; 454: 428-435.